• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Prognostic factors for mortality in patients hospitalized with influenza complications, in Taiwan

tetano

Editor, Senior Moderator
Int Health. 2014 Nov 23. pii: ihu083. [Epub ahead of print]
Prognostic factors for mortality in patients hospitalized with influenza complications, in Taiwan.
Huang WT1, Chang CH2, Hsu YF2, Chuang JH3.
Author information
Abstract
BACKGROUND:

This study aims to assess factors associated with fatal hospitalized influenza with complications in Taiwan.
METHODS:

We identified reports of complications and illness onset in patients hospitalized with influenza between week 26, 2009 and week 25, 2012 from the National Notifiable Disease Surveillance System. We used a multivariate logistic regression model to evaluate covariates that can be associated with in-hospital mortality.
RESULTS:

Among 4735 patients (413 deaths), age ≥50 years (p<0.001), male (p=0.014), comorbidities (p<0.001), and delayed oseltamivir treatment (p<0.001) increased the likelihood of in-hospital mortality.
CONCLUSIONS:

We recommend influenza vaccination and early antiviral treatment for at-risk populations.

? The Author 2014. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
KEYWORDS:

Case fatality rate; Influenza; Mortality determinant; Surveillance; Taiwan

PMID:
25422279
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25422279
 
Back
Top Bottom